- Q1 2024 Embla Medical hf Earnings Call TranscriptApr 23, 2024kr30.7 (+1.99%)Earnings
- Q4 2023 Ossur hf Earnings Call TranscriptJan 30, 2024kr29.65 (+4.40%)Earnings
- Q3 2023 Ossur hf Earnings Call TranscriptOct 24, 2023kr29.3 (+2.99%)Earnings
- Q2 2023 Ossur hf Earnings Call TranscriptJul 25, 2023kr32.4 (+1.73%)Earnings
- Q1 2023 Ossur hf Earnings Call TranscriptApr 25, 2023kr30.75 (-1.76%)Earnings
- Ossur hf Corporate Analyst Meeting TranscriptMar 30, 2023
- Q4 2022 Ossur hf Earnings Call TranscriptJan 31, 2023Earnings
- Q3 2022 Ossur hf Earnings Call TranscriptOct 25, 2022kr32.95 (-1.79%)Earnings
- Q2 2022 Ossur hf Earnings Call TranscriptJul 21, 2022kr31.5 (+5.00%)Earnings
- Preliminary Q2 2022 Ossur hf Earnings Call TranscriptJul 18, 2022kr29.6Earnings
- Q1 2022 Ossur hf Earnings Call TranscriptApr 26, 2022kr36.4 (-5.45%)Earnings
- Q4 2021 Ossur hf Earnings Call TranscriptFeb 01, 2022kr40.6 (+4.10%)Earnings
- Q3 2021 Ossur hf Earnings Call TranscriptOct 26, 2021kr43.2Earnings
- Q2 2021 Ossur hf Earnings Call TranscriptJul 22, 2021kr48 (+1.27%)Earnings
- Q1 2021 Ossur hf Earnings Call TranscriptApr 27, 2021kr47.25 (+2.05%)Earnings
- Q4 2020 Ossur hf Earnings Call TranscriptFeb 02, 2021kr46.25 (+0.22%)Earnings
- Q3 2020 Ossur hf Earnings Call TranscriptOct 27, 2020kr42 (-2.33%)Earnings
- Q2 2020 Ossur hf Earnings Call TranscriptJul 23, 2020kr44.3 (+0.23%)Earnings
- Q1 2020 Ossur hf Earnings Call TranscriptApr 30, 2020kr43.65 (+1.51%)Earnings
- Q4 2019 Ossur hf Earnings Call TranscriptFeb 04, 2020kr49.55 (-0.10%)Earnings
- Full Year 2019 Ossur hf Guidance Call TranscriptJan 14, 2020
- Q3 2019 Ossur hf Earnings Call TranscriptOct 22, 2019kr45.5 (+1.11%)Earnings
- Q2 2019 Ossur hf Earnings Call TranscriptJul 25, 2019kr45.95 (+5.88%)Earnings
- Q1 2019 Ossur hf Earnings Call TranscriptApr 30, 2019kr37.3 (+5.97%)Earnings
Q4 2019 Ossur hf Earnings Call Transcript
Ladies and gentlemen, welcome to the Ãssur Q4 and Full year 2019 Results. Today, I'm pleased to present Mr. Jón Sigurdsson, President and CEO. (Operator Instructions)
Jón, please begin.
° - -&
Yes. Thank you. First of all, I would like to welcome you here to the Ãssur investor conference call where we will cover the results for the full year and the fourth quarter of 2019. My name is Jón Sigurdsson, and I am the President and CEO of Ãssur. And with me here today is Sveinn Sölvason, our CFO.
We will begin by going through the highlights for the quarter, followed by the quarter results and ending with our guidance for 2020. A question-and-answer session will then follow.
Sales for the full year amounted to $686 million, corresponding to 16% growth in local currency and 5% organic growth. EBITDA before special items grew by $35 million or 30% and amounted to $150 million, which corresponds to 22% of sales. Excluding the impact
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)